Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Change in Luotea Plc’s Group Management Team
-
RoadReady Tow Launches Nationwide Towing and Roadside Assistance Service Across 150+ U.S. Cities
-
Data on debtor composition
-
Niu Technologies to Report Third Quarter 2026 Financial Results on Nov 16, 2026
-
Danske Bank share buy-back programme: transactions in week 42
-
FLSmidth appoints Gonzalo Del Carpio as new Chief Operational Excellence Officer to strengthen the foundations for future growth
-
Bang & Olufsen A/S - Transactions in connection with share buyback programme to hedge the company’s share-based incentive programmes
-
Preliminary data on early redemptions (prepayments)
-
Transactions under share buy-back programme
-
Figurobot Launches FR-NIA: A 11-inch Bionic AI Companion Robot Bringing Intelligent Interaction into Everyday Life
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
ISIN DK0030488101 - FRN Tryg Forsikring A/S Subordinated Callable SEK 1,300,000,000 Bond Issue (the "Bonds") - Exercise of Ordinary Call - Key information
-
Q3, 2026
-
BYD Energy Storage Accelerates Global BESS After-Sales Network Expansion
-
Experiencing Mid-Autumn Festival Like a Local in Hong Kong
-
Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
-
Christmas flights 2026: KAYAK reveals fares down up to 39% from the UK
-
Removal of Listing of Ordinary C Shares
-
63/2026・Trifork Group: Weekly report on share buyback
-
Share repurchase programme: Transactions of week 42 2026
-
Share buyback programme – week 42
-
AB Akola Group Increases Its Investment in OMG Bubble Tea and Acquires a Controlling Stake
-
‘Global Perspectives on China’ Dialogue on GDI held in Beijing
-
Expansion of the security segment wholesale business through the acquisition of shares in companies
-
The Smart Luggage at the 140th Canton Fair:Airwheel 20inch Carry-On Hand Scooter Ai Wheel Robot Cabin Luxury Suitcase Takes Smart Travel to the Next Level
-
Exor Press Release - Periodic Report on the Buyback Program
-
Prepayments, Realkredit Danmark A/S
-
RAMSAY GENERALE DE SANTE : Availability of the 2026 URD - Evolution in the Governance - Annual General meeting on 4th December 2026
-
Share Buy-back Programme – Transactions Week 42
-
Egide - Half-year results at June 30, 2026: Net loss more than halved, amounting to €0.87m, Net financial debt reduced to €4.99m
-
Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrki
-
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease
-
tpay Selected as Vodafone Qatar’s Direct Operator Billing Aggregator
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
ALSTOM S.A: Alstom secures a first tranche order worth approximately €800 million in Vietnam
-
Nouscom Raises €120 Million ($135 Million) in Oversubscribed Series D Financing and will Present Long-Term Cancer Interception Clinical Data in Lynch Syndrome Carriers at ESMO
-
MKI Global Partners expands into emerging markets with focus on Latin America
-
OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
-
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
-
Cabka’s emission reduction targets validated by the Science Based Targets initiative
-
Ekalia takes an important step in the deployment of Astatine-211 in the United States through a collaboration agreement with Telix
-
OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
-
4th Liangzhu Forum Opens in Hangzhou to Facilitate Global Heritage Dialogue
-
Red Cat Announces Proposed Voluntary Public Purchase Offer for Steyr Motors
-
JJP Biologics Doses the First Patients in Phase 1b Clinical Trial of Nebaprubart in Rheumatoid Arthritis (RA)
-
Start of Day Message
-
RUBIS ANNOUNCES A PROPOSAL TO CONVERT THE GROUP INTO A JOINT-STOCK COMPANY (SOCIÉTÉ ANONYME)
-
Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830
-
Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio


